December 2020 Issue Table Of Contents

From The Editor

• What’s The Annual Outlook For Life Sciences In 2021?

Feature Articles

• View From The Inside: What’s Shaping Biopharma In 2021 And Beyond?
• From “Musty Towel” To “Golden Age:” Biosimilars In 2021 And Beyond
• COVID-19 And Cell And Gene Sector: Contingency Planning For 2021 And Beyond
• Reflection And Projection — 15 CEOs Map Biopharma’s Present And Future
• AI And Machine Learning Prepare Pharma For The Data Onslaught
• Politics and the Pandemic — Where Are They Taking Biopharma? Industry CEOs Speak Out
• What Do 10 Biopharma Finance Experts Expect for 2021?
• The Future Of Biopharma Manufacturing Has Never Been More Critical
• Can Your CDMO Relationships Survive Another “Virtual” Year?

Capitol Perspectives

• Election Fallout: Can Divided Government Forge Bipartisan Solutions?

From Policy to Execution

• 2020 Experience Will Shape Healthcare Policy Reset In 2021

Industry Research

• Phase 2/3 Outsourced Spend By Provider Type

Leadership Lessons

• “So, You’re Telling Me I’m Not A Rock Star?” — When Feedback Goes Wrong